Editas Medicine, Inc. (EDIT)
1.81
-0.01
(-0.55%)
USD |
NASDAQ |
Feb 09, 16:00
1.81
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Total Assets (Quarterly) : 201.75M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 568.69M |
| Arcutis Biotherapeutics, Inc. | 370.98M |
| Biogen, Inc. | 29.44B |
| Daré Bioscience, Inc. | 30.75M |
| Cogent Biosciences, Inc. | 425.93M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 188.30M |
| Shareholders Equity (Quarterly) | 13.45M |
| Debt to Equity Ratio | 5.852 |
| Current Ratio | 2.864 |
| Net Debt Paydown Yield | -2.47% |